ClinicalTrials.Veeva

Menu

The Additive Analgesic Effects of Transversus Abdominis Plane Block in Abdominoplasty Under Spinal Anaesthesia

H

Helwan University

Status

Completed

Conditions

Transversus Abdominis Plane Block (TAP Block)
Spinal Anaesthesia
Abdominoplasty

Treatments

Drug: Subcostal TAP block and spinal anesthesia group (STAP)
Drug: Spinal anaesthesia group (S)

Study type

Interventional

Funder types

Other

Identifiers

NCT06550180
CT2024-001

Details and patient eligibility

About

The primary outcome is the time to first request of opioid analgesia. The secondary outcomes are intraoperative analgesic needs, incidence of conversion to general anaesthesia, the total opioid dose in 24 hours, Visual analogue scale (VAS) scores at 2, 4, 6, 12, and 24 hours postoperatively, and the incidence of postoperative side effects (nausea, vomiting, hypotension, bradycardia, and pruritic).

Full description

Abdominoplasty is designed to remove fat, skin laxity, and excess skin with the abdominal skin flap. It is a moderately invasive extraperitoneal procedure with or without liposuction. Ambulatory office-based abdominoplasty procedures have recently increased owing to lower cost and global availability of plastic surgeons in addition to better and safer anaesthetic techniques Spinal anaesthesia has many advantages such as pre-emptive analgesia, better control of pain, suppression of the surgical stress response, preservation of perioperative immune function, preservation of oxygenation and pulmonary functional residual capacity and improved visceral vascular flow in addition to reduction in the incidence of venous thrombotic disease and hence pulmonary embolism, as it facilitates early ambulation The addition of adjuvant drugs to local anesthetics and augmenting spinal anesthesia with peripheral nerve blocks would provide time for prolonged surgeries, and it is the ideal technique for procedures below T3-T4. The investigators assume that performing a transversus abdominis plane block (TAP block) just before spinal anesthesia in abdominoplasty would prolong the duration of postoperative analgesia and lessen the number of cases needing sedation or conversion to general anesthesia when compared to spinal anesthesia alone.

Enrollment

66 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anaesthesiologists physical status grade I and grade II.
  • Age > 18 years and less than 65 years.
  • Both sexes.

Exclusion criteria

  • Patient refusal.

    -. Bleeding or coagulation abnormality.

  • Local skin infection and sepsis at site of the block.

  • Known hypersensitivity to the study drugs.

  • Body Mass Index > 50 Kg/m2.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

66 participants in 2 patient groups

Spinal anaesthesia group (S)
Experimental group
Description:
patient in S group They will receive 20 mg of 0.5% hyperbaric bupivacaine plus 25 microgram fentanyl.
Treatment:
Drug: Spinal anaesthesia group (S)
oblique Subcostal TAP block and spinal anaesthesia group (OSTAP)
Experimental group
Description:
Patients in (OSTAP) groups had spinal anesthesia administered with 20 mg of 0.5% hyperbaric bupivacaine and 25 mcg of fentanyl. Immediately after giving spinal anesthesia, individuals in the OSTAP group received 35 ml of 0.25% isobaric bupivacaine on each side.
Treatment:
Drug: Subcostal TAP block and spinal anesthesia group (STAP)

Trial contacts and locations

1

Loading...

Central trial contact

Adel Ali Hassan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems